WO1996025183A3 - Ophthalmic compositions including peptides and peptide derivatives and methods for using same - Google Patents
Ophthalmic compositions including peptides and peptide derivatives and methods for using same Download PDFInfo
- Publication number
- WO1996025183A3 WO1996025183A3 PCT/US1996/001728 US9601728W WO9625183A3 WO 1996025183 A3 WO1996025183 A3 WO 1996025183A3 US 9601728 W US9601728 W US 9601728W WO 9625183 A3 WO9625183 A3 WO 9625183A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- same
- ophthalmic compositions
- compositions including
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Eyeglasses (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicinal Preparation (AREA)
Abstract
Ophthalmic compositions and methods for preserving and using such compositions are disclosed. In one embodiment, such compositions include a liquid medium, a first antimicrobial component selected from antimicrobial peptides and mixtures thereof, and a second antimicrobial component, other than the first antimicrobial component, which is preferably substantially non-oxidative. Compositions which include a liquid medium and antimicrobial peptide nanotubes effective to disinfect a contact lens present in the liquid medium containing the nanotubes are also disclosed. Preserved compositions useful for caring for contact lenses are included within the scope of the present invention.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU48657/96A AU4865796A (en) | 1995-02-17 | 1996-02-08 | Ophthalmic compositions including peptides and peptide derivatives and methods for using same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39000695A | 1995-02-17 | 1995-02-17 | |
US08/390,006 | 1995-02-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996025183A2 WO1996025183A2 (en) | 1996-08-22 |
WO1996025183A3 true WO1996025183A3 (en) | 1996-10-10 |
Family
ID=23540656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/001728 WO1996025183A2 (en) | 1995-02-17 | 1996-02-08 | Ophthalmic compositions including peptides and peptide derivatives and methods for using same |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4865796A (en) |
WO (1) | WO1996025183A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6482799B1 (en) | 1999-05-25 | 2002-11-19 | The Regents Of The University Of California | Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial |
WO2002064183A1 (en) * | 2001-02-09 | 2002-08-22 | Johnson & Johnson Vision Care, Inc. | Biomedical devices with antimicrobial cationic peptide and protein coatings |
US6872705B2 (en) * | 2001-07-13 | 2005-03-29 | Allergan, Inc. | Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions |
US7368127B2 (en) | 2002-12-19 | 2008-05-06 | Johnson & Johnson Vision Care, Inc. | Biomedical devices with peptide containing coatings |
WO2004091438A2 (en) * | 2003-04-15 | 2004-10-28 | Fxs Ventures, Llc | Improved ophthalmic and contact lens solutions containing peptides as representative enhancers |
US8906364B2 (en) * | 2005-07-01 | 2014-12-09 | Kane Biotech Inc. | Antimicrobial compositions and uses thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4659692A (en) * | 1982-11-19 | 1987-04-21 | The Regents Of The University Of California | Cationic oligopeptides having microbicidal activity |
WO1991007192A1 (en) * | 1989-11-21 | 1991-05-30 | Schering Corporation | Contact lens disinfecting system |
US5242902A (en) * | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
WO1994021672A1 (en) * | 1993-03-19 | 1994-09-29 | The Regents Of The University Of California | Novel antimicrobial peptides from bovine neutrophils |
WO1996006532A1 (en) * | 1994-09-01 | 1996-03-07 | Novo Nordisk A/S | A basic protein composition for killing or inhibiting microbial cells |
-
1996
- 1996-02-08 WO PCT/US1996/001728 patent/WO1996025183A2/en active Application Filing
- 1996-02-08 AU AU48657/96A patent/AU4865796A/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4659692A (en) * | 1982-11-19 | 1987-04-21 | The Regents Of The University Of California | Cationic oligopeptides having microbicidal activity |
US5242902A (en) * | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
WO1991007192A1 (en) * | 1989-11-21 | 1991-05-30 | Schering Corporation | Contact lens disinfecting system |
WO1994021672A1 (en) * | 1993-03-19 | 1994-09-29 | The Regents Of The University Of California | Novel antimicrobial peptides from bovine neutrophils |
WO1996006532A1 (en) * | 1994-09-01 | 1996-03-07 | Novo Nordisk A/S | A basic protein composition for killing or inhibiting microbial cells |
Also Published As
Publication number | Publication date |
---|---|
WO1996025183A2 (en) | 1996-08-22 |
AU4865796A (en) | 1996-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2070293A1 (en) | Ophthalmic compositions and methods for preserving and using same | |
CA2070286A1 (en) | Non Oxidative Ophthalmic Compositions and Methods for Preserving and Using Same | |
AU3100195A (en) | Saline solution for treating contact lenses | |
CA2309172A1 (en) | Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions | |
DK0484281T4 (en) | cyclosporines | |
ATE202706T1 (en) | USE OF 9-DEOXYPROSTAGLAND INDERIVATIVES FOR THE TREATMENT OF GLAUCOMA | |
DE69605729D1 (en) | OPHTALMIC COMPOSITIONS CONTAINING AMIDOAMINE | |
MX9710252A (en) | Use of one or more peptides in a cosmetic composition or for the preparation of a medicament. | |
MX9603607A (en) | Insecticidal matrix and process for preparation thereof. | |
MX9701514A (en) | Cleaning, disinfecting and preserving contact lenses. | |
CA2138960A1 (en) | Ophthalmic compositions and methods for preserving and using same | |
WO1996025183A3 (en) | Ophthalmic compositions including peptides and peptide derivatives and methods for using same | |
NO951989L (en) | Use of amidoamines in eye preparations | |
US5549894A (en) | Disinfecton formulations and methods using D-enantiomeric anti-microbial peptides | |
PT789764E (en) | NEW FAMILY OF PROTEASE INHIBITORS AND OTHER ACTIVE BIOLOGICAL SUBSTANCES | |
CA2154179A1 (en) | Compositions and methods to disinfect contact lenses | |
CA2247862A1 (en) | Treatment of contact lenses with aqueous solution including phosphonic compounds | |
WO1996018406A3 (en) | Ophthalmic formulations of substituted glycosides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |